Our Organization BYOMass, Inc.
Our Organization BYOMass, Inc.
Lavender Swirl Background
Partner

BYOMass, Inc.

We are focusing on the brain and how it controls metabolism, more specifically, how it can help maintain body weight and blood pressure.



Aging drives the chronic diseases that are the biggest burden on the medical system, and BYOMass, Inc. has built a compelling case around modulating defined targets to alleviate multi-morbidity.

BYOMass’s therapeutic programs will benefit from the ecosystem Juvenescence is building to accelerate the discovery and development of novel therapeutics to address aging and help patients travel on a path to healthier aging.

BYOMass was founded by Dr. Margaret Jackson, who has led multiple teams and drug discovery efforts in her twenty-year career as a drug developer. Jackson, the CEO of BYOMass, has joined the Juvenescence team as Vice President, Head of Preclinical Research and Development.

In the News

Juvenescence

Juvenescence Capitalizes BYOMass

Juvenescence is pleased to announce its latest equity investment in BYOMass, a Massachusetts-based company focused on central control of metabolism in the context of aging and age-related diseases.

March 26, 2019

Read More

Contact Us

We are here to help answer any questions you might have.